No Clinical Benefit of Intramuscular Delivery of Bone Marrow-derived Mononuclear Cells in Nonreconstructable Peripheral Arterial Disease Results of a Phase-III Randomized-controlled Trial

Author(s):
Lindeman, J.H.N. (0000-0002-5656-4345); Zwaginga, J.J.; Kallenberg-Lantrua, G.; Wissen, R.C. van; Schepers, A.; Bockel, H.J. van; Fibbe, W.E. (0000-0001-8539-9011); Hamming, J.F.
Published
2018
Publication type
Article / Letter to editor
bone marrowclinical trialcritical limb ischemiaperipheral arterial diseaseplacebo-controlledrandomizedstem cell therapy
Date issued
2018-11-30
Language
English
Is part of
Annals of Surgery (2018), Vol. 268, no. 5, p. 756-761
hdl
1887/96240
doi
10.1097/SLA.0000000000002896